Lips or fingertips turning blue, or breathlessness so severe that a full sentence cannot be spoken, needs emergency care right away. Call 911 or go to the emergency department.
Asthma is a long-term condition of airway inflammation in which the airways narrow in a variable way, so symptoms come and go and airflow often returns close to normal in between. COPD, chronic obstructive pulmonary disease, is a long-term condition in which airflow out of the lungs stays limited and does not fully return to normal, usually in the setting of years of inhaled irritant exposure.
The two descriptions sound similar because the end result is similar. Air has to travel through tubes that have become narrower than they should be, and the person feels that as tightness, wheeze, cough or breathlessness. What differs is the machinery behind the narrowing and how fixed it is.
In asthma, the airway wall is inflamed and the smooth muscle wrapped around it is quick to tighten. Mucus production adds to the narrowing. The defining feature is variability. Airflow can be close to normal one morning and clearly reduced the next, and triggers such as allergens, cold air, exercise or a respiratory infection can swing it within minutes to hours.
In COPD, the small airways are thickened and narrowed, and the elastic air sacs that normally hold them open lose structure. Because the lung springs back less, airways tend to collapse during exhalation and air becomes trapped behind them. That is why breathing out feels slow and why the chest can feel full. The pattern builds over years rather than over hours, with flare-ups layered on top.
Both labels are umbrella terms. Asthma covers several patterns, including airway disease with strong allergic features and airway disease that begins in adulthood without them. COPD covers patterns weighted more toward airway inflammation and patterns weighted more toward loss of air sac structure. A clinician works out which pattern fits a person, not just which label.
Eosinophils are a type of white blood cell reported on a standard blood count, and the result is one of several clues a clinician weighs when sorting out a long-term airway condition. That guide covers what the cell does, how the count is measured and how to read a result.
FitScript's optimal range for eosinophils is 1 to 4 %, read alongside the lab's own range as printed on your lab report. Optimal ranges are optimization targets, not diagnostic cut-offs. A value outside the printed range is worth discussing with a clinician, who decides what it reflects in the context of symptoms, exposure history and breathing tests. No single blood number sorts one airway condition from another.
The clearest separators are age at onset, inhaled exposure history, how variable the symptoms are, and how much airflow improves during breathing tests. The table below sets out the patterns clinicians look for, and these are patterns rather than rules, because individual people cross between the columns.
| Feature | Asthma pattern | COPD pattern |
|---|---|---|
| Age symptoms begin | Childhood or young adulthood, though onset in adulthood occurs | Middle age or later, after years of inhaled exposure |
| Inhaled exposure history | May be absent altogether | Central to the picture, including tobacco smoke, occupational dust and fume, biomass smoke and heavy air pollution |
| Symptom pattern | Episodic and variable, with quieter spells in between | Persistent and slowly progressive, punctuated by flare-ups |
| Night and early morning symptoms | A recognised feature | Can occur, less defining |
| Usual triggers | Allergens, exercise, cold air, respiratory infections, strong smells | Respiratory infections, air pollution, exertion |
| Airflow obstruction on breathing tests | Variable, can return close to normal | Persistent, does not fully normalise |
| Change after the medicine step of spirometry | Can be large | Usually smaller |
| Blood eosinophil count | May be raised | Varies widely between people |
| Hay fever or eczema in the history | A recognised part of the history | Not a defining feature |
| Pattern over years | Fluctuates, can stay stable for long stretches | Gradual loss of lung function is characteristic |
Read the table as a weighing of features. A person with several features in one column and none in the other is straightforward. A person with features scattered across both columns is the reason the overlap concept exists at all.
It matters because the label shapes what gets monitored, what gets reviewed and what a clinician expects over time. Two people can arrive with the same complaint of breathlessness on stairs and leave with very different follow-up plans.
Monitoring differs. Variable airflow invites tracking over time, including repeat breathing tests and symptom diaries that capture good days and bad days. Persistent airflow limitation invites a different rhythm of review, with attention to exercise capacity, flare-up frequency and how the lungs change over years.
Exposure counselling differs in emphasis. Where inhaled irritant exposure is part of the picture, stopping that exposure is the single change with the biggest influence on the course of the condition, and a clinician can connect a person to support for it. Where allergic triggers dominate, identifying and reducing those exposures carries more weight.
Expectations differ too. A condition that fluctuates is managed toward good control between episodes. A condition with persistent limitation is managed toward preserving function, capacity and independence. Neither framing is better, they are answers to different questions.
Finally, medicines differ, and that decision is not one to make from an article. Some medicines are used in airway conditions, and which ones suit a particular person is a question for your prescriber. Treatment decisions belong to a licensed provider who has examined the person and reviewed their test results.
Age at onset is one of the most useful clues, but it is a clue rather than a verdict. Asthma commonly begins in childhood or young adulthood, and a history of wheeze as a child, a childhood inhaler, or symptoms that predate any smoking history all point that way. COPD is usually recognised in middle age or later, because persistent airflow limitation takes years of accumulated exposure and age-related change to develop.
The complication is that both ends of the age range are leakier than the textbook suggests. Asthma can begin in adulthood, sometimes after a respiratory infection, sometimes after a new workplace exposure, and sometimes with no identifiable starting event. On the other side, airflow limitation can appear earlier than expected in a person with an inherited reason for it or a heavy occupational exposure history.
There is also a direct link between the two timelines. Research suggests that a history of asthma earlier in life is associated with a diagnosis of COPD later in life 1. That does not mean one condition becomes the other in a simple way, and it does not mean a person with childhood asthma should expect a particular future. It means a clinician assessing an older adult with fixed airflow limitation will ask carefully about childhood breathing, because the answer changes how the current picture is read.
Practically, the question worth answering is not only how old someone is now, but how old they were when breathing first became a problem, and whether there were symptom-free years in between.
Smoking history is one of the strongest pieces of context in the assessment, and clinicians quantify it rather than just noting yes or no. The number of cigarettes per day multiplied over years of smoking gives a cumulative exposure figure, and current versus former smoking matters as well, because stopping changes the trajectory from the point it happens.
It is a mistake, though, to treat smoking history as a switch that selects the diagnosis. Two gaps open up in both directions.
First, airflow limitation develops in people who never smoked. Occupational dust, fume, vapour and gas exposure, smoke from cooking or heating with solid fuel indoors, and sustained heavy air pollution exposure all belong in the history. So does an inherited protein deficiency that affects lung tissue, which is checked with a simple blood test and is worth considering in an adult with airflow limitation and little exposure history.
Second, people with asthma smoke, and smoking does not protect anyone from having asthma. When an adult with long-standing asthma also has a substantial smoking history, the two influences sit on top of each other, symptoms become harder to categorise, and breathing tests can show a mix of variable and fixed components.
So smoking history shifts the probabilities and tells a clinician which exposures to ask about next. It does not, on its own, decide which condition is present, and no article can make that call for an individual.
Spirometry measures how much air a person can blow out and how fast they can blow it, and reversibility means the airflow improves substantially after a medicine given during the test. It is the single most informative test in this comparison, which is why a diagnosis made on symptoms alone is considered incomplete.
The person breathes in fully and then blows out as hard and as long as they can into a mouthpiece. Two numbers carry most of the weight. One is the volume of air moved in the first second of that blow. The other is the total volume moved across the whole blow. The relationship between them describes how obstructed the airways are, because obstruction slows the early part of the blow more than it reduces the total.
The test is then repeated after a medicine step, and the clinician performing it decides what is used and can explain it. If the first-second volume rises clearly, the obstruction is described as reversible, a pattern associated with variable airway narrowing. If it barely moves, the obstruction is described as persistent, a pattern associated with structural change. Many results fall in between.
Two further points stop reversibility from being a clean switch. One is that a single test captures one moment. Someone with asthma tested on a good day may show little room for improvement simply because airflow was already near their best, which is why repeat tests, peak flow readings taken at home over a period, or an airway challenge test may be added. The other is that people with long-standing airway disease can develop limitation that no longer fully reverses, and some people with persistent limitation still show a sizeable improvement on the day.
Research suggests that chronic airflow obstruction spans both conditions and that no single agreed definition divides them cleanly, which is one reason the overlap category was proposed at all 2. A spirometry result outside the printed expected values is worth discussing with the clinician who ordered it, who decides what it reflects.
Symptoms narrow the field but rarely settle it, because wheeze, cough, chest tightness and breathlessness belong to both conditions. What differs is the shape the symptoms take over time.
The asthma shape is episodic. Symptoms arrive in bouts, often wake the person in the early hours, and attach themselves to identifiable triggers such as pollen, animals, dust, cold air, exercise, strong smells or a chest infection. Between bouts a person may feel completely well and perform normally on breathing tests.
The COPD shape is cumulative. Breathlessness on exertion creeps in and stays, often noticed first on hills or stairs, and it gradually claims activities the person used to do without thinking. A long-standing cough bringing up sputum may be present for years. Flare-ups sit on top of a baseline that does not return all the way to normal.
In practice, the history is harder to read than those two paragraphs imply. People adapt to breathlessness by doing less, so they under-report it. Symptoms are described differently by different people, and a person with both an exposure history and allergic features gives a history that reads both ways. Describing the pattern honestly, including what has been given up rather than only what is still being done, gives the clinician more to work with than a symptom checklist.
Asthma and COPD overlap describes a person who has persistent airflow limitation alongside features normally associated with asthma, such as variability, allergic history or a raised eosinophil count. It is a descriptive category rather than a single disease with a single test.
The category is genuinely contested. A narrative review of epidemiology and practice examined whether the overlap syndrome exists as a distinct entity and found that definitions, and therefore the populations described, vary between sources 3. Separate commentary has described the overlap syndrome as a controversial concept rather than a settled diagnosis 4. That disagreement is not a footnote, it is the reason two clinicians can look at the same person and apply different labels.
Work on definitions and management has set out the overlap as chronic airflow obstruction accompanied by features of both conditions, while noting that important questions about how to define and manage it remain open 2. Allergy is one of the features that recurs. Research suggests that allergic mechanisms have a role in at least some people with overlap, which is why allergic history and allergy testing feature in the assessment 5.
An increasingly used alternative is to stop arguing about the label and describe what is actually present. Work in this area asks whether the overlap is better handled as a treatable trait, or as several traits that each need addressing, rather than as one diagnosis 6. In plain terms, that means documenting the specific features a person has, such as persistent obstruction, variability, an allergic history or a raised eosinophil count, and letting a clinician address each one.
For an individual, the useful takeaway is that being hard to classify is a recognised situation, not a failure of testing, and that a clinician can still act on the features that are present.
Airway disease that begins early in life can leave a person with airflow limitation that no longer fully reverses, and this is one of the routes into the overlap picture. Research suggests that a history of asthma earlier in life is associated with a later COPD diagnosis 1.
Several things plausibly contribute. Lungs grow through childhood and adolescence, and anything that interferes with that growth can leave a lower peak lung function to decline from in later decades. Years of airway inflammation can also change the structure of the airway wall, so that the narrowing becomes less responsive than it once was. Added inhaled exposures compound both.
What this does not mean is that a person with childhood asthma is on a track to a specific outcome.
What it does mean is practical. Childhood breathing history belongs in the notes of an adult being assessed for breathlessness, even if it was decades ago and even if there were symptom-free years in between. It also means an adult with a known early airway history has a clear reason to have lung function measured rather than estimated, because a baseline is only useful if it was actually recorded.
Related: Reactive Airway Disease vs Asthma: What the Label Means
Beyond spirometry, clinicians draw on breath tests, blood tests, imaging and further lung function tests, each answering a narrow question rather than giving a verdict.
A breath test for fractional exhaled nitric oxide measures a gas produced in inflamed airways. A scoping review of this breath test in COPD and in asthma and COPD overlap indicates it may help flag the type of airway inflammation more typical of asthma, while reported values overlap between groups enough that it is read alongside everything else 7.
Allergy testing can include skin testing and blood tests for allergen-specific antibodies, plus a total antibody level. A clear allergic profile strengthens the asthma side of the picture, and its absence does not remove it.
Fuller lung function tests measure how much air the lungs hold, how much stays trapped after a full breath out, and how efficiently gas crosses from air sacs into blood. Reduced gas transfer points toward loss of air sac structure rather than airway narrowing alone, which is useful when spirometry is ambiguous.
Chest imaging is used mainly to look for other explanations and for structural change, not to label the condition. Oximetry at rest and during walking adds information about how the lungs perform under load. A blood test for an inherited protein deficiency affecting lung tissue is worth considering in an adult with airflow limitation and limited exposure history.
None of these tests names a condition on its own. A clinician assembles them with the history, and a result outside the printed range is worth discussing with that clinician, who decides what it reflects.
Breathlessness, cough and wheeze have many sources outside the airways, and sorting them out is part of the assessment rather than an afterthought. These possibilities are listed without ranking, because ranking them for an individual is a clinician's job.
Heart function is a major alternative route to breathlessness, particularly breathlessness that worsens when lying flat or comes with ankle swelling. Anaemia reduces the oxygen-carrying capacity of blood and can present as breathlessness on exertion with a normal chest examination. Thyroid function influences exercise tolerance. Deconditioning after a long period of reduced activity produces real, measurable breathlessness that improves with graded activity.
In the airways themselves, bronchiectasis produces a chronic productive cough and repeated infections. Vocal cord dysfunction produces noisy breathing in on exertion or under stress and is frequently mistaken for wheeze. A cough following a respiratory infection can persist for weeks. Reflux and post-nasal drip contribute to chronic cough. Some medicines cause cough as a side effect, which is a question for your prescriber rather than something to work out alone. Sleep-disordered breathing, assessed with sleep tests, adds daytime fatigue and breathlessness that neither airway condition explains on its own.
Anxiety affects breathing patterns, and it can coexist with airway disease rather than replace it. None of these should be assumed before a proper assessment, and none should be dismissed either. If symptoms do not fit the airway story, say so to your clinician and ask what else is being considered.
A small group of blood markers adds useful context around an airway question, without any of them naming a condition.
The full blood count carries the eosinophil result and more besides. Haemoglobin addresses the anaemia question directly. The neutrophil count and the overall white cell picture shift during and after infection, which is relevant because an eosinophil count taken during a flare-up or an infection may not represent a person's usual state.
Allergy-related blood tests include a total antibody level and tests for antibodies to specific allergens, which help describe the allergic side of the picture. General markers of inflammation can be checked in words rather than as a target, and they are non-specific, rising in many situations.
A blood test for the inherited protein deficiency affecting lung tissue is a one-time test with lasting value in the right person. Thyroid markers and iron markers address alternative explanations for exertional breathlessness. Vitamin D is commonly included in general panels and is interpreted on its own terms.
Timing matters more than most people expect. An eosinophil count varies between measurements, and a result taken while unwell is harder to interpret, so repeat measurements over time give a steadier picture than one reading. FitScript tests 150+ biomarkers per year and Atlas, the AI health advisor, reads each result against the rest of a member's biology rather than in isolation.
Breathlessness that is new, worsening, or limiting what a person can do is a reason to be assessed, and it should not be filed under getting older or being unfit without a proper look.
Some signs need emergency care. Lips or fingertips turning blue, breathlessness so severe that a full sentence cannot be spoken, confusion or drowsiness with breathing difficulty, chest pain with breathlessness, or coughing up blood all mean calling 911 or going to the emergency department now. Do not wait to see whether these settle.
Speak to a clinician promptly, rather than at the next routine opportunity, for breathlessness that is clearly worse than usual over days, a flare-up that is not responding as it normally would, waking at night breathless, new swelling of the legs alongside breathlessness, or a cough that has changed character or persisted for several weeks.
Book a routine assessment for long-standing cough, wheeze on exertion, breathing symptoms with a smoking or occupational exposure history, or childhood asthma that was never followed up in adulthood. Ask specifically for breathing tests, because symptoms alone cannot settle the question and an unmeasured lung is an unknown lung.
Bring the useful details with you, including when symptoms began, what triggers them, what the pattern is across a week, your full exposure history, and any blood results you already have. Discuss your results and any treatment with a clinician or licensed provider, who decides what happens next. This page is educational and is not medical advice.
Yes, a person can have persistent airflow limitation alongside features normally associated with asthma, such as variability, an allergic history or a raised eosinophil count. Clinicians describe this situation as overlap, and definitions of it differ between sources. Being hard to classify is a recognised situation rather than a testing failure, and a clinician can still act on the specific features that are present.
No single blood value separates them. The eosinophil count describes one type of inflammation and is read alongside age at onset, exposure history, symptom pattern and breathing tests. A count outside the range printed on your lab report is worth discussing with a clinician, who decides what it reflects.
They are different conditions rather than stages of one another, but airway disease that began early in life can leave airflow limitation that no longer fully returns to normal. That is one of the routes into the overlap picture. It is a reason to mention childhood breathing history to your clinician, not a prediction about any individual.
Spirometry is the main one. It measures how much air you can blow out and how fast, then repeats the measurement after a medicine step so the clinician can see how much the airflow improves. Large improvement points one way and persistent limitation points the other, and many results sit in between, so the test is read alongside the full history.
No. Airflow limitation develops in people who never smoked, including after long-term occupational dust or fume exposure, smoke from indoor cooking or heating fuel, or heavy air pollution exposure. An inherited protein deficiency affecting lung tissue is another reason, and it is checked with a simple blood test. Your clinician decides which of these is worth testing for.
The symptoms themselves overlap heavily, since both can cause wheeze, cough, chest tightness and breathlessness. What tends to differ is the shape over time. Episodic symptoms that flare with identifiable triggers and settle in between point one way, while breathlessness that builds slowly over years and does not fully return to baseline points the other.
In COPD the airflow limitation persists and does not fully return to normal during a breathing test, and that persistence is part of how the condition is described. This does not mean nothing can change. Stopping ongoing inhaled exposure, staying active and attending reviews all influence the course, and a licensed provider decides what else is appropriate for a given person.
Lips or fingertips turning blue, breathlessness so severe that you cannot speak a full sentence, confusion or drowsiness with breathing difficulty, chest pain with breathlessness, or coughing up blood all need emergency care immediately. Call 911 or go to the emergency department. Do not wait to see whether these signs settle.